174 related articles for article (PubMed ID: 8625212)
1. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
[TBL] [Abstract][Full Text] [Related]
2. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening.
Tanaka T; Sugimoto T; Sawada T
Cancer; 1998 Oct; 83(8):1626-33. PubMed ID: 9781958
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara A; Azar CG; Scavarda NJ; Brodeur GM
Mol Cell Biol; 1994 Jan; 14(1):759-67. PubMed ID: 8264643
[TBL] [Abstract][Full Text] [Related]
5. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
[TBL] [Abstract][Full Text] [Related]
7. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
8. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
9. Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis.
Matsunaga T; Shirasawa H; Enomoto H; Yoshida H; Iwai J; Tanabe M; Kawamura K; Etoh T; Ohnuma N
Int J Cancer; 1998 Jun; 79(3):226-31. PubMed ID: 9645342
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
Combaret V; Gross N; Lasset C; Balmas K; Bouvier R; Frappaz D; Beretta-Brognara C; Philip T; Favrot MC; Coll JL
Br J Cancer; 1997; 75(8):1151-5. PubMed ID: 9099963
[TBL] [Abstract][Full Text] [Related]
11. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
Miyake M; Suzuki T; Shimada H; Stram D; Seeger RC
Prog Clin Biol Res; 1994; 385():163-8. PubMed ID: 7972208
[No Abstract] [Full Text] [Related]
12. Expression of TrkA, TrkB and TrkC in human neuroblastomas.
Brodeur GM; Nakagawara A; Yamashiro DJ; Ikegaki N; Liu XG; Azar CG; Lee CP; Evans AE
J Neurooncol; 1997 Jan; 31(1-2):49-55. PubMed ID: 9049830
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of Trk-C in favourable human neuroblastomas.
Yamashiro DJ; Liu XG; Lee CP; Nakagawara A; Ikegaki N; McGregor LM; Baylin SB; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):2054-7. PubMed ID: 9516852
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of molecular markers in neuroblastoma: results from a single institution.
Gallego S; Parareda A; Munell F; Sanchez de Toledo J; Reventos J
Oncol Rep; 1999; 6(4):891-6. PubMed ID: 10373677
[TBL] [Abstract][Full Text] [Related]
15. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors.
Donovan MJ; Hempstead BL; Horvath C; Chao MV; Schofield D
Am J Pathol; 1993 Dec; 143(6):1560-7. PubMed ID: 8256848
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
[TBL] [Abstract][Full Text] [Related]
18. trk and ret proto-oncogene expression in human neuroblastoma specimens: high frequency of trk expression in non-advanced stages.
Borrello MG; Bongarzone I; Pierotti MA; Luksch R; Gasparini M; Collini P; Pilotti S; Rizzetti MG; Mondellini P; De Bernardi B
Int J Cancer; 1993 Jun; 54(4):540-5. PubMed ID: 8514446
[TBL] [Abstract][Full Text] [Related]
19. Abundant but inactive-state gp140proto-trk is expressed in neuroblastomas of patients with good prognosis.
Iwata H; Ito T; Mutoh T; Ishiguro Y; Xiao H; Hamaguchi M
Jpn J Cancer Res; 1994 Jan; 85(1):32-9. PubMed ID: 7508904
[TBL] [Abstract][Full Text] [Related]
20. Activation of TRK genes in Ewing's sarcoma. Trk A receptor expression linked to neural differentiation.
Nogueira E; Navarro S; Pellín A; Llombart-Bosch A
Diagn Mol Pathol; 1997 Feb; 6(1):10-6. PubMed ID: 9028732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
